(2023). Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationStatement of Retraction: Methyldopa Versus Labetalol or No Medication for Treatment of Mild and Moderate Chronic Hypertension During Pregnancy: A Randomized Clinical Trial. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationStatement of Retraction: Methyldopa Versus Labetalol or No Medication for Treatment of Mild and Moderate Chronic Hypertension During Pregnancy: A Randomized Clinical Trial. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.